765 related articles for article (PubMed ID: 22515091)
1. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel.
Agrawal R; Shanavas A; Yadav S; Aslam M; Bahadur D; Srivastava R
J Biomed Nanotechnol; 2012 Feb; 8(1):19-28. PubMed ID: 22515091
[TBL] [Abstract][Full Text] [Related]
2. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
4. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
[TBL] [Abstract][Full Text] [Related]
7. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.
Qiao C; Zhang K; Jin H; Miao L; Shi C; Liu X; Yuan A; Liu J; Li D; Zheng C; Zhang G; Li X; Yang B; Sun H
Int J Nanomedicine; 2013; 8():2985-95. PubMed ID: 23990717
[TBL] [Abstract][Full Text] [Related]
8. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
10. PLA/PLGA nanoparticles for sustained release of docetaxel.
Musumeci T; Ventura CA; Giannone I; Ruozi B; Montenegro L; Pignatello R; Puglisi G
Int J Pharm; 2006 Nov; 325(1-2):172-9. PubMed ID: 16887303
[TBL] [Abstract][Full Text] [Related]
11. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):158-64. PubMed ID: 21764569
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.
Bowerman CJ; Byrne JD; Chu KS; Schorzman AN; Keeler AW; Sherwood CA; Perry JL; Luft JC; Darr DB; Deal AM; Napier ME; Zamboni WC; Sharpless NE; Perou CM; DeSimone JM
Nano Lett; 2017 Jan; 17(1):242-248. PubMed ID: 27966988
[TBL] [Abstract][Full Text] [Related]
13. Poly(lactic-co-glycolic) Acid/Solutol HS15-Based Nanoparticles for Docetaxel Delivery.
Cho HJ; Park JH; Kim DD; Yoon IS
J Nanosci Nanotechnol; 2016 Feb; 16(2):1433-6. PubMed ID: 27433600
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
[TBL] [Abstract][Full Text] [Related]
15. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
Avgoustakis K
Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
[TBL] [Abstract][Full Text] [Related]
16. Optimization of parameters for preparation of docetaxel-loaded PLGA nanoparticles by nanoprecipitation method.
Shi W; Zhang ZJ; Yuan Y; Xing EM; Qin Y; Peng ZJ; Zhang ZP; Yang KY
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):754-758. PubMed ID: 24142732
[TBL] [Abstract][Full Text] [Related]
17. Release retardation of model protein on polyelectrolyte-coated PLGA nano- and microparticles.
Nugraha C; Bora M; Venkatraman SS
PLoS One; 2014; 9(3):e92393. PubMed ID: 24647768
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible amphiphilic pentablock copolymeric nanoparticles for anti-cancer drug delivery.
Byagari K; Shanavas A; Rengan AK; Kundu GC; Srivastava R
J Biomed Nanotechnol; 2014 Jan; 10(1):109-19. PubMed ID: 24724503
[TBL] [Abstract][Full Text] [Related]
20. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
Nandakumar V; Geetha V; Chittaranjan S; Doble M
Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
